³Ô¹Ï±¬ÁÏ Unveils Powerful New Digital Tools to Enable
the Future of On-demand Physician Engagement
³Ô¹Ï±¬ÁÏ CRM Engage Connect adds new ways for seamless communication
among healthcare providers and field teams
PLEASANTON, CA ¡ª Nov. 18, 2021 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today showcased the ³Ô¹Ï±¬ÁÏ CRM Engage Connect compliant messaging and content sharing capabilities at its European ³Ô¹Ï±¬ÁÏ Commercial and Medical Summit Connect event. Healthcare professionals (HCPs) will now have access to the information and resources they need from life sciences companies when they need them. Engage Connect will be available next month as part of the ³Ô¹Ï±¬ÁÏ Engage app used by over one million HCPs for digital meetings.
When HCPs need information, it¡¯s hard to know which field reps and companies to contact. Physicians want to easily search and send text requests¡ªwithout sharing their personal information. With compliant messaging, field teams can have more timely and purposeful exchanges in between meetings or events.
¡°With ³Ô¹Ï±¬ÁÏ Engage Connect, our field teams can quickly connect with HCPs in a more personal, convenient way through compliant texts, scheduling meetings, and most importantly, sharing patient resources,¡± said Deborah Sullivan, director, field force automation, Sanofi. ¡°The app allows us to personalize customer interactions while giving HCPs a one-stop-shop where they can proactively connect with reps from across the industry for support that ultimately helps improve patient¡¯s lives.¡±
³Ô¹Ï±¬ÁÏ Engage Connect makes chat-like messaging and content sharing simple and compliant. Field teams can more easily stay connected with HCPs via:
- Compliant, two-way messaging: Pharma reps and medical science liaisons (MSLs) can securely chat with HCP customers anytime, anywhere to deliver timely information on potential treatments.
- On demand content and resources: HCPs can quickly find or request educational materials, samples, patient resources, or services.
- Simple scheduling: HCPs can request in-person or remote meetings, show office hour preferences, view upcoming meetings, and launch video calls directly from the app.
¡°Doctors prefer interacting with reps and MSLs on their terms and are asking for more convenient access to information and resources,¡± said Bryce Davis, senior director, ³Ô¹Ï±¬ÁÏ Engage strategy. ¡°³Ô¹Ï±¬ÁÏ Engage Connect is helping deepen relationships between HCPs and life sciences companies by enabling simple two-way engagement across multiple companies and brands in a single app¡ªadvancing the industry toward a pharma on demand world.¡±
Engage Connect is part of the ³Ô¹Ï±¬ÁÏ Engage platform that enables anytime, any channel engagement through video, phone calls, contactless in-person interactions, or chat. Initially introduced to early adopters as My³Ô¹Ï±¬ÁÏ for Doctors, the new ³Ô¹Ï±¬ÁÏ Engage Connect capabilities will be available for biopharma field teams next month. HCPs will be able to connect and meet with participating life science commercial teams using their existing ³Ô¹Ï±¬ÁÏ Engage app, which is available in the and .
To learn more about the ³Ô¹Ï±¬ÁÏ Engage platform, life sciences industry professionals can register for today¡¯s ³Ô¹Ï±¬ÁÏ Commercial and Medical Summit Connect Europe at veeva.com/eu/summit. ³Ô¹Ï±¬ÁÏ also released news about new innovations to ³Ô¹Ï±¬ÁÏ CRM at today¡¯s Summit.
Additional InformationFor more on ³Ô¹Ï±¬ÁÏ CRM Engage Connect, visit: veeva.com/EngageConnect
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Forward-looking StatementsThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-Q for the period ended July 31, 2021. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.
###Contact:
Deivis Mercado³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49 6950955486
jeremy.whittaker@veeva.com